Remote Health Monitoring Market Size, Share, and Trends 2024 to 2034

Remote Health Monitoring Market (By Devices: Respiratory monitoring, Blood Glucose Monitoring, Cardiac Monitoring, Multi-Parameter Monitoring; By Application: Oncology, Cardiovascular Diseases, Diabetes, Others; By End-Users: Hospitals, Home Health Care, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : August 2024
  • Report Code : 2491
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Remote Health Monitoring Market 

5.1. COVID-19 Landscape: Remote Health Monitoring Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Remote Health Monitoring Market, By Devices

8.1. Remote Health Monitoring Market, by Devices, 2024-2034

8.1.1 Respiratory monitoring

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Blood glucose monitoring

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Cardiac monitoring

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Multi-parameter monitoring

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Remote Health Monitoring Market, By Application

9.1. Remote Health Monitoring Market, by Application, 2024-2034

9.1.1. Multi-parameter monitoring

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Cardiovascular diseases

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Diabetes

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Remote Health Monitoring Market, By End-Users 

10.1. Remote Health Monitoring Market, by End-Users, 2024-2034

10.1.1. Others

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Home health care

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Diagnostic centers

10.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Remote Health Monitoring Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Devices (2021-2034)

11.1.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Devices (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Devices (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Devices (2021-2034)

11.2.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Devices (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Devices (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Devices (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Devices (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Devices (2021-2034)

11.3.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Devices (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Devices (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Devices (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Devices (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Devices (2021-2034)

11.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Devices (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Devices (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Devices (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Devices (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Devices (2021-2034)

11.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Devices (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End-Users (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Devices (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End-Users (2021-2034)

Chapter 12. Company Profiles

12.1. Philips

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Medtronic

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. A&D Company Limited

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. G.E. Healthcare

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Boston Scientific Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Nihon Kohden Corporation

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. 100-Plus

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. F-Hoffman-La-Roche AG

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client